Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huang Yang

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|January 20, 2011
Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformationMarina Khrapunovich-Baine, Vilas Menon, Chia-Ping Huang Yang, et al.
Cancer Research|December 7, 2007
Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppressionMarie-Emmanuelle Legrier, Chia-Ping Huang Yang, Han-Guang Yan, et al.
Steroids|September 6, 2011
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Huang-Yang Chen, et al.
Current Drug Metabolism|October 15, 2019
Expression Level of MiRNA-126 in Serum Exosomes of Allergic Asthma Patients and Lung Tissues of Asthmatic MiceMeizhen Zhao, Yu-Pei Li, Xiao-Rui Geng, et al.
Gynecologic Oncology|May 11, 2015
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome AtlasBrandon-Luke L Seagle, Chia-Ping Huang Yang, Kevin H Eng, et al.
Molecular Cancer Therapeutics|June 16, 2005
A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependenceChia-Ping Huang Yang, Pascal Verdier-Pinard, Fang Wang, et al.
Mediators of Inflammation|April 11, 2020
ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 AxisZhou Shangxun, Li Junjie, Zhao Wei, et al.
Revista Brasileira De Ginecologia E Obstetricia : Revista Da Federacao Brasileira Das Sociedades De Ginecologia E Obstetricia|May 24, 2023
Development of a Mobile Health Application Based on a Mixed Prenatal Care in the Context of COVID-19 PandemicRommy Helena Novoa, Luis Meza-Santibañez, Noe Rodríguez-Hilario, et al.
Nucleic Acids Research|December 22, 2022
CK2 promotes jasmonic acid signaling response by phosphorylating MYC2 in ArabidopsisJiang Zhu, Wen-Shu Wang, Da-Wei Yan, et al.
Immunity, Inflammation and Disease|February 6, 2025
Diagnostic and Prognostic Value of Serum Golgi Protein 73 in Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver FailureZheng-Ju Xu, Tao Xu, Qiao-Xia Ye, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|January 20, 2011
Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformationMarina Khrapunovich-Baine, Vilas Menon, Chia-Ping Huang Yang, et al.
Cancer Research|December 7, 2007
Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppressionMarie-Emmanuelle Legrier, Chia-Ping Huang Yang, Han-Guang Yan, et al.
Steroids|September 6, 2011
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Huang-Yang Chen, et al.
Current Drug Metabolism|October 15, 2019
Expression Level of MiRNA-126 in Serum Exosomes of Allergic Asthma Patients and Lung Tissues of Asthmatic MiceMeizhen Zhao, Yu-Pei Li, Xiao-Rui Geng, et al.
Gynecologic Oncology|May 11, 2015
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome AtlasBrandon-Luke L Seagle, Chia-Ping Huang Yang, Kevin H Eng, et al.
Molecular Cancer Therapeutics|June 16, 2005
A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependenceChia-Ping Huang Yang, Pascal Verdier-Pinard, Fang Wang, et al.
Mediators of Inflammation|April 11, 2020
ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 AxisZhou Shangxun, Li Junjie, Zhao Wei, et al.
Revista Brasileira De Ginecologia E Obstetricia : Revista Da Federacao Brasileira Das Sociedades De Ginecologia E Obstetricia|May 24, 2023
Development of a Mobile Health Application Based on a Mixed Prenatal Care in the Context of COVID-19 PandemicRommy Helena Novoa, Luis Meza-Santibañez, Noe Rodríguez-Hilario, et al.
Nucleic Acids Research|December 22, 2022
CK2 promotes jasmonic acid signaling response by phosphorylating MYC2 in ArabidopsisJiang Zhu, Wen-Shu Wang, Da-Wei Yan, et al.
Immunity, Inflammation and Disease|February 6, 2025
Diagnostic and Prognostic Value of Serum Golgi Protein 73 in Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver FailureZheng-Ju Xu, Tao Xu, Qiao-Xia Ye, et al.
Pageof 15